Renaissance Technologies’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.79M | Buy |
+45,200
| New | +$3.79M | 0.01% | 1695 |
|
2023
Q4 | – | Sell |
-61,554
| Closed | -$1.82M | – | 4095 |
|
2023
Q3 | $1.82M | Sell |
61,554
-4,500
| -7% | -$133K | ﹤0.01% | 1926 |
|
2023
Q2 | $283K | Sell |
66,054
-10,461
| -14% | -$44.8K | ﹤0.01% | 3154 |
|
2023
Q1 | $164K | Buy |
76,515
+26,761
| +54% | +$57.4K | ﹤0.01% | 3347 |
|
2022
Q4 | $99K | Buy |
49,754
+4,800
| +11% | +$9.55K | ﹤0.01% | 3621 |
|
2022
Q3 | $75K | Buy |
44,954
+8,279
| +23% | +$13.8K | ﹤0.01% | 3667 |
|
2022
Q2 | $102K | Buy |
36,675
+20,128
| +122% | +$56K | ﹤0.01% | 3849 |
|
2022
Q1 | $55K | Buy |
16,547
+12,507
| +310% | +$41.6K | ﹤0.01% | 3897 |
|
2021
Q4 | $25K | Buy |
4,040
+3,347
| +483% | +$20.7K | ﹤0.01% | 3834 |
|
2021
Q3 | $10K | Sell |
693
-24,253
| -97% | -$350K | ﹤0.01% | 3414 |
|
2021
Q2 | $427K | Buy |
+24,946
| New | +$427K | ﹤0.01% | 3023 |
|
2020
Q3 | – | Sell |
-9,617
| Closed | -$320K | – | 3656 |
|
2020
Q2 | $320K | Buy |
9,617
+1,853
| +24% | +$61.7K | ﹤0.01% | 3017 |
|
2020
Q1 | $277K | Sell |
7,764
-953
| -11% | -$34K | ﹤0.01% | 3007 |
|
2019
Q4 | $384K | Sell |
8,717
-1,708
| -16% | -$75.2K | ﹤0.01% | 2987 |
|
2019
Q3 | $235K | Buy |
10,425
+898
| +9% | +$20.2K | ﹤0.01% | 3099 |
|
2019
Q2 | $400K | Buy |
9,527
+5,285
| +125% | +$222K | ﹤0.01% | 3076 |
|
2019
Q1 | $131K | Buy |
+4,242
| New | +$131K | ﹤0.01% | 3271 |
|
2017
Q4 | – | Sell |
-354
| Closed | -$14K | – | 3488 |
|
2017
Q3 | $14K | Buy |
+354
| New | +$14K | ﹤0.01% | 3163 |
|